Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma
Clinical trial NCT04804696 · TERMINATED
Trial details
- NCT number
- NCT04804696
- Sponsor
- Peking University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-10
- Primary completion
- 2024-11-29
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.